BioPharmSignal logoBioPharmSignal

Biotech News

First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT

Stereotaxis (STXS)StereotaxisConference / presentation

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the findings from the first-in-human clinical results for Robocath’s next-generation robotic system during the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. The findings support a favorable performance profile for the system, with 100% clinical success rate and no device-related complications.

Related news

STXSStereotaxis2026-10-22 12:04 EST

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

STXSStereotaxis2026-10-30 12:03 EST

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

TMCITreace Medical Concepts2026-09-17 21:16 EST

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

MMSIMerit Medical2026-11-05 14:25 EST

Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry

PLSEPulse Biosciences2026-10-08 11:00 EST

Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026

TMCITreace Medical Concepts2026-11-03 21:05 EST

Treace to Present at the Stifel 2026 Healthcare Conference

OMOutset Medical2026-10-27 20:05 EST

Outset Medical to Participate in the 2026 Stifel Healthcare Conference

ICUIICU Medical2026-11-06 13:30 EST

ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London

ICUSeaStar Medical2026-09-29 12:36 EST

SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026

PLSEPulse Biosciences2026-10-29 17:05 EST

Pulse Biosciences to Present at Stifel 2026 Healthcare Conference

View all latest news

Stereotaxis

Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures. Magnetic Navigation Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control. Integrated Procedure Suite The MAGiC...

Recent company news

STXSStereotaxis2026-11-02 13:48 EST

First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT

STXSStereotaxis2026-10-30 12:03 EST

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

STXSStereotaxis2026-10-22 12:04 EST

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

STXSStereotaxis2026-10-20 11:40 EST

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

STXSStereotaxis2026-09-16 11:59 EST

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Stock data

Close
1.05 USD
Market cap
192.54M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States